In-Person Symposium
Friday, December 8, 2023
7:00 am – 10:00 am PT
Marriott Marquis San Diego Marina,
San Diego Ballroom AB,
San Diego, California

Register Now

ACTIVITY OVERVIEW

The 2023 Symposium will focus on recent advances in the diagnosis, classification and management of patients with myelodysplastic syndromes (MDS). The program combines recent data, application of new tools and evidence on current practice with information that might be applied in the future.

AGENDA TOPICS

• MDS challenges in 2023
• A classification of myelodysplastic syndromes that aids clinical decision-making
• Pre-MDS states: CH, CCUS, ICUS – How to manage in the clinic?
• Erythroid stimulating agents (ESA)- Still the 1st line for LR-MDS?
• Artificial intelligence in MDS practice
• Can we do better than HMA alone in HR-MDS?
• Should cytoreduction precede transplant?
• Patient discussion session

LEARNING OBJECTIVES

Participants will learn about novel information obtained over the last decade and will hear about potential applications in the field of MDS.

More specifically practitioners and researchers:

• Will understand the current challenges in the field of diagnosis, prognosis and therapy
• Will acquire more clarity about recent classifications
• Will learn about the pre-MDS conditions, how to identify, follow, and possibly manage
• Develop an approach to managing anemia in lower risk MDS
• Will learn about personalizing therapy and maximizing clinical outcomes in higher risk disease
• Will appreciate the controversies surrounding cytoreduction prior to stem cell transplant.
• Will solidify their knowledge by practical application of learning in real-life case discussions

FACULTY

Moshe Mittelman, MD – Symposium Co-Chair

Professor of Medicine
Department of Medicine
Tel-Aviv Sourasky Medical Center
Tel-Aviv University Medical School
Tel-Aviv, Israel

Rena Buckstein, MD – Symposium Co-Chair

Associate Professor, Department of Medicine
Odette Cancer Center
Toronto, Ontario, Canada

Stephen Nimer, MD – MDSF Chairman

Director, Sylvester Comprehensive Cancer Center
Professor of Medicine, Biochemistry & Molecular Biology
University of Miami Miller School of Medicine
Miami, Florida, USA

Mario Cazzola, MD

Professor of Hematology
Fondazione IRCCS Policlinico San Matteo
University of Pavia
Pavia, Italy

Jane Churpek, MD

Assistant Professor
University of Wisconsin School of Medicine and Public Health
Carbone Cancer Center
Madison, Wisconsin, USA

Matteo Della Porta, MD

Humanitas Research Hospital, & Humanitas University
Rozzano Milan, Italy

Guillermo Garcia-Manero, MD

McCredie Professor of Medicine
Vice Chair, Department of Leukemia
Chief, Section of MDS
The University of Texas MD Anderson Cancer Center
Houston, TX, USA

Aristoteles Giagounidis, MD

The University of Texas MD Anderson Cancer Center
Houston, TX, USA

Christopher Gibson, MD

Dana Farber Cancer Institute
Boston, MA, USA

Aziz Nazha, MD

Cleveland Clinic
Cleveland, OH, USA

Uwe Platzbecker, MD

Director
Medical Clinic and Policlinic 1
Hematology and Cellular Therapy
University Hospital Leipzig
Leipzig, Germany

Guillermo Sanz, MD

Head, Clinical Hematology & Hematopoietic
Cell Transplantation Unit
Hospital Universitario y Politecnico La Fe
Valencia, Spain

Michael R. Savona, MD

Professor of Medicine and Cancer Biology
Vanderbilt University School of Medicine
Nashville, Tennessee, USA

Lewis Silverman, MD

Icahn School of Medicine at Mount Sinai
Director Translational Research Center for the Myelodysplastic Syndrome
Tisch Cancer Institute
New York City, New York, USA

AGENDA

Co-Chairs: Moshe Mittelman, MD (Tel-Aviv, Israel) & Rena Buckstein, MD (Toronto, Canada)

*Activity and faculty subject to change

Register Now

**Please note that CME Credits will only be available to those who attend live to continuing education credits. CME is typically for physicians only; the event offers credit for pharmacy and nurses.